Asieris Pharma gets China NMPA approval to begin phase ? trial of Hexvix to treat bladder cancer

Asieris Pharma gets China NMPA approval to begin phase ? trial of Hexvix to treat bladder cancer

By, Admin 15 February 2022

Asieris Pharmaceuticals, a global innovative biopharma company, announced that Hexvix, a drug for diagnosis of for bladder cancer has obtained the clinical trial application (CTA) approval from the National Medical Products Administration (NMPA) of China. The study is a prospective, self-controlled, multicenter phase ? trial aimed to investigate the additional detection rate and safety of Hexvix and blue light cystoscopy (BLC) versus white light cystoscopy in patients with non-muscle invasive bladder cancer (NMIBC) (CIS, Ta, T1). The study will be led by Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Professor Li Hanzhong, head of the Department of Surgery, Peking Union Medical College Hospital, will serve as the Principal Investigator to lead a team of top experts in the field of bladder cancer in China to carry out this study. The company plans to file a new drug application to the NMPA in the future pending clinical trial progress and meaningful data. According to the 2020 global cancer data released by the World Health Organization

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!